Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Identify effective ways to increase income to pay off debt. Maximize your earnings and take control of your financial future.
22,636 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Crypto markets are cooling as macro policy tightens and Bitcoin stalls on a breakout. This combination has led to a d...
The S&P 500 faced renewed selling on March 24, 2026, as traders weighed higher yields and mixed earnings. The stock m...
Meta Platforms faced a $119 billion market-cap drop as regulators threaten stricter data, privacy and ad rules. Analy...
Toncoin roars higher as Bitcoin rebounds from the $81,000 level, pushing ton’s weekly gains reach into triple digits....
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
Intel’s stock falling guiding the chip sector into a rough day as inflation data raises concerns about data-center sp...
XRP trades near $1.50 in mid-May 2026 as traders weigh a potential move to $3 this year. Regulatory clarity and liqui...
U.S. stocks edge lower as Iran tensions escalate, with the SPY and major indexes slipping while oil climbs and safe-h...
HYPE breaks above $57 as a short squeeze pushes the token within 2% of its all-time high, with negative funding and s...
Emerging markets can surprise investors with big moves. This article explains how a notable fund outpaced its benchma...
U.S. stocks moved higher as traders shrugged off renewed fighting in Iran, with gains led by technology and consumer ...